Back to company

PHARMACONTROL ApS: Financial statements 2013

CVR: 31074916

PHARMACONTROL ApS (CVR 31074916) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,764,021 and a net result of DKK 729,921 compared with DKK 996,040 the year before. That is a decrease of 2.6% compared with the year before. Equity amounted to DKK 141,012. The solvency ratio was 9.5%.

Gross Profit
1,764,021 kr.
Profit/Loss
729,921 kr.
Equity
141,012 kr.
Total Assets
1,484,540 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013-1.8 mio.730 t.141 t.-
2012-1.8 mio.996 t.141 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMACONTROL ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

Carl Johan Dam Jensen joins the board of PHARMACONTROL ApSDec 1, 2013

As of December 1, 2013, Carl Johan Dam Jensen has joined the board of directors of PHARMACONTROL ApS.

Doris Larsen joins the board of PHARMACONTROL ApSDec 1, 2013

As of December 1, 2013, Doris Larsen has joined the board of directors of PHARMACONTROL ApS.

Jakob Dam Jensen joins the board of PHARMACONTROL ApSDec 1, 2013

As of December 1, 2013, Jakob Dam Jensen has joined the board of directors of PHARMACONTROL ApS.

PHARMACONTROL ApS: The 2012 annual report is outMay 15, 2013

PHARMACONTROL ApS has published its annual report for 2012. Gross profit came to DKK 1,811,508, and the net result was DKK 996,040.

About PHARMACONTROL ApS

PHARMACONTROL ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2007. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Carl Johan Dam Jensen. The company is owned by DAM JENSEN HOLDING ApS. The company has 4 employees. In 2025, the company reported a gross profit of DKK 1,032,293 and a net result of DKK 15,881 compared with DKK 269,844 the year before. Equity amounted to DKK 637,199.